OCT New England 2023 | ICON plc

Thank you for speaking with the ICON team at OCT New England 2023

We invite you to explore the resources we have assembled below to demonstrate how we can support your clinical development pipeline.

Contact us for more information or to arrange a meeting with our experts.

Factsheets:

Paediatric Risk Assessment Map

Identifying and mitigating risks in paediatric clinical trials.

Accellacare In-Home Services

Reducing patient burden.

Biotech Services Overview

Transformative therapies start with transformative approaches.

Concierge Services

Guiding patients and site through clinical trials.

Decentralized Clinical Trial Solutions

Delivering quality data quicker for faster time to market.

Digital Platform

Integrating patient, site, and study services for clinical trials.

ICON Central Laboratories

Single global network of ICON-owned laboratories.

ICON Early Clinical & Bioanalytical Solutions

Innovative early phase solutions that will advance your drug development strategy.

Navigating the EU CTR in early phase clinical trials

Lessons learned and timelines to approval based on experience so far in the Netherlands.

Brochures:

Medical Imaging Solutions

Quality imaging data delivered by industry experts.

ICON Specialty Laboratories

Supporting precision medicine programs across all phases of drug diagnostic co-development.

Commercialisation & Outcomes Solutions

An overview of ICON's commercialisation and outcomes services.

Whitepaper:

Biotech and Early Engagement Considerations

What companies must consider when developing an asset.

Case Study:

Phase 3 Multiple Myeloma Trial

Expedited study start-up for central radiology and clinical data review.

Webinar:

Navigating the new EU CTR in early phase clinical trials

Lessons learned and timelines to approval based on experience so far.